Silk fibroin hydrogels crosslinked through di-tyrosine bonds are clear, elastomeric constructs with immense potential in regenerative medicine applications. In this study, demonstrated is a new visible light-mediated photoredox system for di-tyrosine bond formation in silk fibroin that overcomes major limitations of current conventional enzymatic-based crosslinking. This photomediated system rapidly crosslinks silk fibroin (<1 min), allowing encapsulation of cells at significantly higher cell densities (15 million cells mL ) while retaining high cell viability (>80%). The photocrosslinked silk hydrogels present more stable mechanical properties which do not undergo spontaneous transition to stiff, β-sheet-rich networks typically seen for enzymatically crosslinked systems. These hydrogels also support long-term culture of human articular chondrocytes, with excellent cartilage tissue formation. This system also facilitates the first demonstration of biofabrication of silk fibroin constructs in the absence of chemical modification of the protein structure or rheological additives. Cell-laden constructs with complex, ordered, graduated architectures, and high resolution (40 µm) are fabricated using the photocrosslinking system, which cannot be achieved using the enzymatic crosslinking system. Taken together, this work demonstrates the immense potential of a new crosslinking approach for fabrication of elastomeric silk hydrogels with applications in biofabrication and tissue regeneration.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/adhm.201901667 | DOI Listing |
Front Chem
December 2024
Department of Orthopaedics, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Introduction: Two-dimensional (2D) MXene, recognized for its outstanding physical and chemical properties,has gained attention as a promising material in the biomedical field. However, its potential in tissue engineering applications remains underexplored. This study focuses on synthesizing SF-MXene composite electrospun fibers and evaluating their suitability for biomedical applications.
View Article and Find Full Text PDFInt J Biol Macromol
January 2025
Department of Chemistry, Faculty of Science, Damanhour University, Damanhour, Egypt.
The effective adsorption of (mercuric ions) Hg onto synthesized and characterized composite materials based on calcium alginate (CG), zinc metal-organic farmwork (MOF-2), and silk fibroin powder (SF) has been reported in this study. Under various application conditions, the adsorption capacities of silk fibroin powder/zinc metal organic framework/alginate composite (ZSG) were compared with those of the other individual solid materials. These solid adsorbents materials were characterized by various physicochemical techniques.
View Article and Find Full Text PDFInt J Biol Macromol
January 2025
State Key Laboratory of Tea Plant Biology and Utilization, Joint Research Center for Food Nutrition and Health of IHM and Anhui Provincial Key Laboratory of Food Safety Monitoring and Quality Control, Anhui Agricultural University, Hefei 230036, PR China; College of Food and Nutrition, Anhui Agricultural University, Hefei 230036, PR China. Electronic address:
To mitigate the risk associated with water-soluble fluoride in tea and to have less influence on the contents of tea infusion, a highly selective lanthanum modified silk fibroin (SF) and polyvinyl alcohol (PVA) composite film (SF/PVA-La) was prepared to remove fluoride from brick tea infusion. Notably, SF/PVA-La could remove about 48 % of the fluoride from in brick tea infusion within 30 min. Importantly, the reduction in total tea polyphenols in brick tea did not exceed 10 %, and the reduction in caffeine was only 0.
View Article and Find Full Text PDFJ Drug Target
January 2025
Department of Pharmaceutics, Yenepoya Pharmacy College & Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, 575018, India.
Breast cancer (BC) is a substantial reason for cancer-related mortality among women across the globe. Anastrozole (ANS) is an effective orally administered hormonal therapy for estrogen+ (ER+) BC treatment. However, several side effects and pharmacokinetic limitations restricted its uses in BC treatment.
View Article and Find Full Text PDFTheranostics
January 2025
Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!